CNPFX
Price
$74.01
Change
+$0.08 (+0.11%)
Updated
Jun 2 closing price
Net Assets
164.3B
WAGSX
Price
$12.54
Change
-$0.09 (-0.71%)
Updated
Jun 2 closing price
Net Assets
12.57M
Interact to see
Advertisement

CNPFX vs WAGSX

Header iconCNPFX vs WAGSX Comparison
Open Charts CNPFX vs WAGSXBanner chart's image
CNPFX vs WAGSX Comparison Chart in %
View a ticker or compare two or three
VS
CNPFX vs. WAGSX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPFX is a Hold and WAGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPFX has more cash in the bank: 164B vs. WAGSX (12.6M). CNPFX pays higher dividends than WAGSX: CNPFX (1.12) vs WAGSX (0.00). CNPFX was incepted earlier than WAGSX: CNPFX (24 years) vs WAGSX (7 years). WAGSX (2.81) is less costly to investors than CNPFX (0.83). WAGSX is a more actively managed with annual turnover of: 43.00 vs. CNPFX (23.00). CNPFX has a lower initial minimum investment than WAGSX: CNPFX (250) vs WAGSX (2000). CNPFX annual gain was more profitable for investors over the last year : 14.01 vs. WAGSX (-2.77). CNPFX return over 5 years is better than : 20.84 vs. WAGSX (-16.52).
CNPFXWAGSXCNPFX / WAGSX
Total Expense Ratio0.831.3661%
Annual Report Gross Expense Ratio0.832.8130%
Fund Existence24 years7 years-
Gain YTD7.3002.850256%
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets164B12.6M1,301,587%
Annual Yield % from dividends1.120.00-
Returns for 1 year14.01-2.77-505%
Returns for 3 years44.6620.52218%
Returns for 5 years20.84-16.52-126%
Returns for 10 years127.07N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WCPSX44.10N/A
N/A
Communication Services UltraSectorProSvc
CBBYX7.20N/A
N/A
AB Relative Value Advisor
DRISX22.31N/A
N/A
North Square Small Cap Value I
BRWTX30.32N/A
N/A
MFS Blended Research Growth Eq R3
REEIX21.67N/A
N/A
RBC Emerging Markets Equity I